Journal
CELL REPORTS
Volume 24, Issue 1, Pages 47-55Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2018.06.008
Keywords
-
Categories
Funding
- U.S. Public Health Service [K99 CA-215315, R01 DK-113984, R01 DK-40936, P30 DK-059635, UL1TR000142]
- Canadian Institutes of Health Research
Ask authors/readers for more resources
Obesity is associated with colon cancer pathogenesis, but the underlying mechanism is actively debated. Here, we confirm that diet-induced obesity promotes tumor growth in two murine colon cancer models and show that this effect is reversed by an orally administered controlled-release mitochondrial protonophore (CRMP) that acts as a liver-specific uncoupler of oxidative phosphorylation. This agent lowered circulating insulin, and the reduction of tumor growth was abrogated by an insulin infusion raising plasma insulin to the level of high-fat-fed mice. We also demonstrate that hyperinsulinemia increases glucose uptake and oxidation in vivo in tumors and that CRMP reverses these effects. This study provides evidence that perturbations of whole-organism energy balance or hepatic energy metabolism can influence neoplastic growth. Furthermore, the data show that glucose uptake and utilization by cancers in vivo are not necessarily constitutively high but rather may vary according to the hormonal milieu.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available